We are live on ! Find out more
WAT icon

Waters Corp

409.38 USD
-4.18
1.01%
At close Updated Sep 4, 4:00 PM EDT
Pre-market
After hours
409.38
0.00
0%
1 day
-1.01%
5 days
0.83%
1 month
3.36%
3 months
8.74%
6 months
28.32%
Year to date
7.18%
1 year
36.6%
5 years
-3.22%
10 years
161.27%
 

About: Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.

Employees: 7,900

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 52.4%
Neutral 47.6%
Negative 0%
Positive
Zacks Investment Research
4 days ago
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
Positive
Benzinga
11 days ago
This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
Neutral
Business Wire
11 days ago
LetsGetChecked Powered by Fuze Health Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients
WEST CHESTER, Ohio--(BUSINESS WIRE)--LetsGetChecked now offers the most comprehensive FDA-cleared at-home HPV screening tool available in the U.S.
LetsGetChecked Powered by Fuze Health Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients
Neutral
PRNewsWire
12 days ago
Waters Corporation to Present at the Wells Fargo Healthcare Conference
MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
Waters Corporation to Present at the Wells Fargo Healthcare Conference
Positive
Seeking Alpha
15 days ago
Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the second quarter. The fund was underweight in the communication services, health care and consumer discretionary sectors. Strong stock selection and an overweight in IT added to relative return. Weakness in energy partially offset the favorable results.
Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
Positive
MarketBeat
29 days ago
Waters Q2 Earnings Call Highlights
Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic Solutions businesses. The company raised its full-year outlook for organic revenue, acquired-business revenue and adjusted earnings per share after results exceeded its prior guidance.
Waters Q2 Earnings Call Highlights
Positive
Zacks Investment Research
1 month ago
Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised
WAT tops Q2 estimates, raises its 2026 outlook and posts broad-based growth across organic and acquired businesses.
Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised
Positive
Seeking Alpha
1 month ago
Oakmark Global Strategy Q2 2026 Portfolio Activity
Despite strong delivery, Accor shares trade at a discount to asset-light peers, leaving room for a re-rating underpinned by durable free cash flow conversion. In our view, Amrize is a fundamentally strong business that is flying under the radar of U.S. investors. Compass Group's scale, operational excellence, and decentralized operating model position it well to capitalize on the ever-growing addressable market and see consistent growth and margin progression over time.
Oakmark Global Strategy Q2 2026 Portfolio Activity
Neutral
Seeking Alpha
1 month ago
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Waters (WAT) Q2 Earnings and Revenues Beat Estimates
Waters (WAT) came out with quarterly earnings of $3.05 per share, beating the Zacks Consensus Estimate of $3.01 per share. This compares to earnings of $2.95 per share a year ago.
Waters (WAT) Q2 Earnings and Revenues Beat Estimates
Price charts implemented using Lightweight Charts™